Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells

Yu-Chih Liang, Shu-Huei Tsai, Linda Chen, Shoei Yn Lin-Shiau, J. K. Lin

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Resveratrol (3,5,4′-trihydroxystilbene), a phytoalexin found in grapes and other food products, has been shown to have cancer chemopreventive activity. However, the mechanism of the anti-carcinogenic activity is not well understood. Here, we offer a possible explanation of its anti-tumor effect. Based on flow cytometric analysis, resveratrol inhibited the proliferation of HT29 colon cancer cells and resulted in their accumulation in the G2 phase of the cell cycle. Western blot analysis and kinase assays demonstrated that the perturbation of G2 phase progression by resveratrol was accompanied by the inactivation of p34CDC2 protein kinase, and an increase in the tyrosine phosphorylated (inactive) form of p34CDC2. Kinase assays revealed that the reduction of p34CDC2 activity by resveratrol was mediated through the inhibition of CDK7 kinase activity, while CDC25A phosphatase activity was not affected. In addition, resveratrol-treated cells were shown to have a low level of CDK7 kinase-Thr161-phosphorylated p34CDC2. These results demonstrated that resveratrol induced cell cycle arrest at the G2 phase through the inhibition of CDK7 kinase activity, suggesting that its anti-tumor activity might occur through the disruption of cell division at the G2/M phase.

Original languageEnglish
Pages (from-to)1053-1060
Number of pages8
JournalBiochemical Pharmacology
Volume65
Issue number7
DOIs
Publication statusPublished - Apr 1 2003

Fingerprint

HT29 Cells
Colon
Phosphotransferases
Carcinoma
G2 Phase
Cells
Cell Division
Tumors
Assays
CDC2 Protein Kinase
Neoplasms
Vitis
Cell Cycle Checkpoints
resveratrol
Phosphoric Monoester Hydrolases
Colonic Neoplasms
Protein Kinases
Tyrosine
Cell Cycle
Western Blotting

Keywords

  • CDC25A
  • CDK7
  • Cell cycle
  • p34
  • Resveratrol

ASJC Scopus subject areas

  • Pharmacology

Cite this

Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. / Liang, Yu-Chih; Tsai, Shu-Huei; Chen, Linda; Lin-Shiau, Shoei Yn; Lin, J. K.

In: Biochemical Pharmacology, Vol. 65, No. 7, 01.04.2003, p. 1053-1060.

Research output: Contribution to journalArticle

Liang, Yu-Chih ; Tsai, Shu-Huei ; Chen, Linda ; Lin-Shiau, Shoei Yn ; Lin, J. K. / Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. In: Biochemical Pharmacology. 2003 ; Vol. 65, No. 7. pp. 1053-1060.
@article{e2762c33d3064af3a9d6ed995155108a,
title = "Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells",
abstract = "Resveratrol (3,5,4′-trihydroxystilbene), a phytoalexin found in grapes and other food products, has been shown to have cancer chemopreventive activity. However, the mechanism of the anti-carcinogenic activity is not well understood. Here, we offer a possible explanation of its anti-tumor effect. Based on flow cytometric analysis, resveratrol inhibited the proliferation of HT29 colon cancer cells and resulted in their accumulation in the G2 phase of the cell cycle. Western blot analysis and kinase assays demonstrated that the perturbation of G2 phase progression by resveratrol was accompanied by the inactivation of p34CDC2 protein kinase, and an increase in the tyrosine phosphorylated (inactive) form of p34CDC2. Kinase assays revealed that the reduction of p34CDC2 activity by resveratrol was mediated through the inhibition of CDK7 kinase activity, while CDC25A phosphatase activity was not affected. In addition, resveratrol-treated cells were shown to have a low level of CDK7 kinase-Thr161-phosphorylated p34CDC2. These results demonstrated that resveratrol induced cell cycle arrest at the G2 phase through the inhibition of CDK7 kinase activity, suggesting that its anti-tumor activity might occur through the disruption of cell division at the G2/M phase.",
keywords = "CDC25A, CDK7, Cell cycle, p34, Resveratrol",
author = "Yu-Chih Liang and Shu-Huei Tsai and Linda Chen and Lin-Shiau, {Shoei Yn} and Lin, {J. K.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0006-2952(03)00011-X",
language = "English",
volume = "65",
pages = "1053--1060",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells

AU - Liang, Yu-Chih

AU - Tsai, Shu-Huei

AU - Chen, Linda

AU - Lin-Shiau, Shoei Yn

AU - Lin, J. K.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Resveratrol (3,5,4′-trihydroxystilbene), a phytoalexin found in grapes and other food products, has been shown to have cancer chemopreventive activity. However, the mechanism of the anti-carcinogenic activity is not well understood. Here, we offer a possible explanation of its anti-tumor effect. Based on flow cytometric analysis, resveratrol inhibited the proliferation of HT29 colon cancer cells and resulted in their accumulation in the G2 phase of the cell cycle. Western blot analysis and kinase assays demonstrated that the perturbation of G2 phase progression by resveratrol was accompanied by the inactivation of p34CDC2 protein kinase, and an increase in the tyrosine phosphorylated (inactive) form of p34CDC2. Kinase assays revealed that the reduction of p34CDC2 activity by resveratrol was mediated through the inhibition of CDK7 kinase activity, while CDC25A phosphatase activity was not affected. In addition, resveratrol-treated cells were shown to have a low level of CDK7 kinase-Thr161-phosphorylated p34CDC2. These results demonstrated that resveratrol induced cell cycle arrest at the G2 phase through the inhibition of CDK7 kinase activity, suggesting that its anti-tumor activity might occur through the disruption of cell division at the G2/M phase.

AB - Resveratrol (3,5,4′-trihydroxystilbene), a phytoalexin found in grapes and other food products, has been shown to have cancer chemopreventive activity. However, the mechanism of the anti-carcinogenic activity is not well understood. Here, we offer a possible explanation of its anti-tumor effect. Based on flow cytometric analysis, resveratrol inhibited the proliferation of HT29 colon cancer cells and resulted in their accumulation in the G2 phase of the cell cycle. Western blot analysis and kinase assays demonstrated that the perturbation of G2 phase progression by resveratrol was accompanied by the inactivation of p34CDC2 protein kinase, and an increase in the tyrosine phosphorylated (inactive) form of p34CDC2. Kinase assays revealed that the reduction of p34CDC2 activity by resveratrol was mediated through the inhibition of CDK7 kinase activity, while CDC25A phosphatase activity was not affected. In addition, resveratrol-treated cells were shown to have a low level of CDK7 kinase-Thr161-phosphorylated p34CDC2. These results demonstrated that resveratrol induced cell cycle arrest at the G2 phase through the inhibition of CDK7 kinase activity, suggesting that its anti-tumor activity might occur through the disruption of cell division at the G2/M phase.

KW - CDC25A

KW - CDK7

KW - Cell cycle

KW - p34

KW - Resveratrol

UR - http://www.scopus.com/inward/record.url?scp=0037378391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037378391&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(03)00011-X

DO - 10.1016/S0006-2952(03)00011-X

M3 - Article

VL - 65

SP - 1053

EP - 1060

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 7

ER -